V
ABBV icon

ViaWealth’s AbbVie ABBV Stock Holding History

ViaWealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9M Buy
13,318
+34
+0.3% +$7.54K 1.61% 13
2025
Q4 		$3.04M Sell
13,284
-734
-5% -$167K 1.71% 13
2025
Q3 		$3.25M Buy
14,018
+214
+2% +$43.6K 1.77% 12
2025
Q2 		$2.56M Sell
13,804
-643
-4% -$120K 1.51% 13
2025
Q1 		$3.03M Sell
14,447
-304
-2% -$59.1K 1.87% 11
2024
Q4 		$2.62M Sell
14,751
-48
-0.3% -$8.82K 1.58% 12
2024
Q3 		$2.92M Buy
14,799
+54
+0.4% +$10.1K 1.7% 12
2024
Q2 		$2.53M Buy
14,745
+728
+5% +$121K 1.57% 15
2024
Q1 		$2.55M Buy
14,017
+183
+1% +$31.5K 1.6% 15
2023
Q4 		$2.14M Buy
13,834
+628
+5% +$91.6K 1.47% 16
2023
Q3 		$1.97M Buy
13,206
+1,671
+14% +$245K 1.45% 16
2023
Q2 		$1.55M Buy
11,535
+152
+1% +$22.3K 1.16% 18
2023
Q1 		$1.81M Buy
11,383
+16
+0.1% +$2.45K 1.44% 17
2022
Q4 		$1.84M Buy
+11,367
New +$1.74M 1.51% 14

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ViaWealth's ABBV Position: Q1 2026 in Review

ViaWealth increased its AbbVie (ABBV) stake by 0.26% in Q1 2026, buying an estimated $7.54K and bringing the position to 13,318 shares worth $2.9M. The position accounts for 1.61% of the portfolio, ranked #13.

ViaWealth first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.25M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • ViaWealth held 13,318 shares of AbbVie worth $2.9M as of Q1 2026.
  • ViaWealth bought 34 AbbVie shares in Q1 2026, an estimated $7.54K.
  • AbbVie made up 1.61% of ViaWealth's portfolio in Q1 2026, its #13 holding.
  • ViaWealth first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • ViaWealth's AbbVie position peaked at $3.25M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on ViaWealth's 13F filing for Q1 2026, filed 11 May 2026.